Sobi is seeking strategic, culture-enabling and collaborative leader to serve as the Executive Director, National Field Director within the Immunology Franchise, leading the U.S. field organization for two uncontrolled, severe gout therapies—one potentially launching in 2026 (pending FDA approval) and another in 2028 (pending NDA submission and FDA approval). This leader will set the vision, culture, and direction for a team of Area Business Directors, Regional Business Directors, Clinical Account Managers, Strategic Account Directors, and Infusion Education support roles across the United States. 

Reporting to the Head of U.S. Immunology and Global Gout Franchise, this role will be pivotal in shaping and executing the commercial field strategy for both launches, ensuring sustained success across the gout portfolio, and realization of each asset’s performance ...